Neurology Today

📰 The July 3 issue of Neurology Today is live! Featuring stories on the new Alzheimer’s blood test, research funding cuts, fremanezumab’s benefit for depression & migraine, and more. Catch the recap on Neurology Today in 5! 🎧 @BrainHealthMD @AANMember hubs.la/Q03vGSTY0

Artificial intelligence is helping neurologists better predict the progression of multiple sclerosis and soon could support earlier, more personalized treatment decisions: hubs.la/Q03xQRBs0 #NeuroTwitter @AANMember @KKultima @SickKidsNews @UppsalaUni @ucl @nyulangone

The July 17 issue of #NeurologyToday is live! Check out stories about a new therapy for giant-cell arteritis, how #AI is reshaping #MS predictions, the link between #OraHealth and neurologic disease, and more: hubs.la/Q03xBhcg0 #NeuroTwitter @BrainHealthMD @AANMember

💸 Federal research cuts are reshaping academic neurology. Leaders like Dr. Jeste say institutions must adapt to protect early-career researchers. @gordonsmithMD @ChildrensLA @AANMember #NeuroTwitter hubs.la/Q03vMQRB0

🧪 The FDA’s approval of a blood test for Alzheimer’s offers promise—but also raises concerns about misuse and misinterpretation. Experts urge education and caution. hubs.ly/Q03xQ_yl0 @RenegadeSynapse @WakeForestMed @AANMember #NeuroTwitter

Via @ScienceTM: A trial of a new adenoviral vector vaccine for meningitis B drew mixed response: hubs.la/Q03xQXYN0 #NeuroTwitter @AANMember @ajpollard1 @UniofOxford @UniOfSurrey @imperialcollege @EmoryUniversity

Via @NEJM: Stroke patients given tenecteplase before thrombectomy had better outcomes than those who just had thrombectomy, possibly opening the door to more research on timing/delivery: hubs.la/Q03xQTTQ0 @AANMember @eva_mistry @amrsarrajMD @TudorGJovin @lrwechsler

New research is strengthening the link between oral health and brain health—including risks for Alzheimer’s, stroke, and cognitive decline: hubs.la/Q03xQLsf0 #NeuroTwitter @AANMember @beiwu66 @CyprienRivier @ColumbiaMed @NYUNursing @YaleMed @UofSC

A new @AANMember position statement guides neurologists on how to approach novel therapies with limited evidence for neurologic conditions: hubs.la/Q03xQLxQ0 #NeuroTwitter @LBGoldsteinMD @UK_HealthCare

Neurologists are turning to #philanthropy to fund innovative programs. Learn how departments build donor relationships: hubs.la/Q03xFqdh0 #NeuroTwitter #fundraising @AANMember @OchsnerHealth @UCSFMedicine @ShafeeqLadha @UCD_Neurology

Via @NEJM: Upadacitinib significantly improves sustained remission in patients with giant-cell arteritis: hubs.la/Q03xBhNQ0 #NeuroTwitter @AANMember @nyugrossman @CUEyeCenter @SWEnglishMD @HopkinsMedicine

Via @GreenJournal: A personalized home aerobic #exercise program can safely improve fitness in people with #neuromuscular disease—and is as effective as hospital-based options: hubs.la/Q03xBhNv0 #NeuroTwitter @AmsterdamUMC @MGHNeurology @PaganoniMDPhD @CheriBlauwetMD

📚 What makes a great peer reviewer? Dr. Jose Merino of @GreenJournal and others share insights from the editorial front lines. @beckerbarroso @AANMember #NeuroTwitter hubs.la/Q03vN9WM0

🧬 Anti-retrovirals may lower Alzheimer’s risk, says Dr. Jayakrishna Ambati of @UVA. Promising data, more research needed. @AANMember #NeuroTwitter hubs.la/Q03vNc510

🧠 Shingles vaccine may cut dementia risk by 20%, says Dr. Pascal Geldsetzer of @StanfordMed. A simple shot, big impact. @PGeldsetzer1 @AANMember #NeuroTwitter hubs.la/Q03vN6JK0

💊 Fremanezumab reduces both migraine & depression symptoms, says Dr. Richard B. Lipton of @EinsteinMed. A promising dual benefit. @DawnBuse @AANMember #NeuroTwitter hubs.la/Q03vN5Dg0

🛌 Longer time in bed post-stroke may signal small vessel disease risk, says Dr. Dillys Xiaodi Liu of @UCSF. Sleep data could be key in stroke care. @phx_ua @AANMember #NeuroTwitter hubs.la/Q03vN5Zn0

🧬 Healthy lifestyle choices may offset the brain risks of shortened telomeres, says Dr. Christopher D. Anderson of Harvard. A hopeful step for stroke, dementia & depression prevention. @CDAndersonMD @AANMember #NeuroTwitter hubs.la/Q03vN3N20

Neurology Today wishes you a safe and happy Independence Day!

🧪 The FDA’s approval of a blood test for Alzheimer’s offers promise—but also raises concerns about misuse and misinterpretation. Experts urge education and caution. @RenegadeSynapse @WakeForestMed @AANMember #NeuroTwitter hubs.la/Q03vMWzT0